OTHER INCOME, GAINS OR LOSSES

6 Months Ended

12 Months Ended

Sep. 30, 2024

Mar. 31, 2024

Notes and other explanatory information [abstract]

OTHER INCOME, GAINS OR LOSSES

7 OTHER INCOME, GAINS OR LOSSES

		Six months ended			Six months ended
	Notes	30 September 2024			30 September 2023
		USD			USD
Fair value change
Preferred shares	(a)		3,539,648			5,044,000
Convertible loan notes	(b)		(274,000	)		(126,000	)
Bank interest income			71			332
Subsidies from government authorities			12,806			19,230
Other			6			6,866
			3,278,531			4,944,428

(a) The preferred shares were fair valued, using an equity allocation model at the end of each reporting period, which resulted in a gain of $3,539,648 for the period ended 30 September 2024 (30 September 2023: a gain of $5,044,000).

(b) The Group has issued 8% convertible loan notes. At 30 September 2024, there were $4,350,000 notes outstanding (30 September 2023: $3,350,000). The notes were fair valued at the end of each reporting period, resulting in a loss of $274,000 during the period ended 30 September 2024 (30 September 2023: loss of $126,000).

7 OTHER INCOME, GAINS OR (LOSSES)

		Year ended			Year ended
	Notes	31 March 2024			31 March 2023
		USD			USD
Fair value change
Preferred shares	(a)		4,101,000			(1,841,000	)
Convertible loan notes	(b)		(374,000	)		(19,000	)
Bank interest income			873			576
Subsidies from government authorities			19,230			67,433
Other			6,885			29,581
			3,753,988			(1,762,410	)

(a)	The preferred shares were fair valued, using an equity allocation model at the end of each reporting period, which resulted in a gain of $4,101,000 for the year ended 31 March 2024 (2023: loss of $1,841,000).
(b)	During the year ended 31 March 2024 and 2023, the Group issued 8% convertible loan notes. At 31 March 2024, there were outstanding notes with aggregate face values of $3,350,000 (2023: $3,250,000). The notes were fair valued at the end of each reporting period, resulting in a loss of $374,000 for the year ended 31 March 2024 (2023: loss of $19,000).